Trial intelligence / Profile preview

Effect of Hydrocodone Bitartrate ER on QT/QTc in Healthy Adults

NCT02243241Phase 1Completed

Sponsor
Purdue Pharma
Start
Nov 2012
Primary completion
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of hydrocodone in pain (3 arms), sponsored by Purdue Pharma. Primary endpoint: Time-matched analysis on QT data corrected for heart rate based on an individual correction method at Day 15. Started Nov 2012; status: completed.

02

Drugs

hydrocodone
03

Conditions

pain

Beyond the preview

Go deeper on NCT02243241.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02243241.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call